- Mohammadi, Abbas;
- Etemad, Behzad;
- Zhang, Xin;
- Li, Yijia;
- Bedwell, Gregory J;
- Sharaf, Radwa;
- Kittilson, Autumn;
- Melberg, Meghan;
- Crain, Charles R;
- Traunbauer, Anna K;
- Wong, Colline;
- Fajnzylber, Jesse;
- Worrall, Daniel P;
- Rosenthal, Alex;
- Jordan, Hannah;
- Jilg, Nikolaus;
- Kaseke, Clarety;
- Giguel, Francoise;
- Lian, Xiaodong;
- Deo, Rinki;
- Gillespie, Elisabeth;
- Chishti, Rida;
- Abrha, Sara;
- Adams, Taylor;
- Siagian, Abigail;
- Dorazio, Dominic;
- Anderson, Peter L;
- Deeks, Steven G;
- Lederman, Michael M;
- Yawetz, Sigal;
- Kuritzkes, Daniel R;
- Lichterfeld, Mathias D;
- Sieg, Scott;
- Tsibris, Athe;
- Carrington, Mary;
- Brumme, Zabrina L;
- Castillo-Mancilla, Jose R;
- Engelman, Alan N;
- Gaiha, Gaurav D;
- Li, Jonathan Z
Non-suppressible HIV-1 viremia (NSV) is defined as persistent low-level viremia on antiretroviral therapy (ART) without evidence of ART non-adherence or significant drug resistance. Unraveling the mechanisms behind NSV would broaden our understanding of HIV-1 persistence. Here we analyzed plasma virus sequences in eight ART-treated individuals with NSV (88% male) and show that they are composed of large clones without evidence of viral evolution over time in those with longitudinal samples. We defined proviruses that match plasma HIV-1 RNA sequences as 'producer proviruses', and those that did not as 'non-producer proviruses'. Non-suppressible viremia arose from expanded clones of producer proviruses that were significantly larger than the genome-intact proviral reservoir of ART-suppressed individuals. Integration sites of producer proviruses were enriched in proximity to the activating H3K36me3 epigenetic mark. CD4+ T cells from participants with NSV demonstrated upregulation of anti-apoptotic genes and downregulation of pro-apoptotic and type I/II interferon-related pathways. Furthermore, participants with NSV showed significantly lower HIV-specific CD8+ T cell responses compared with untreated viremic controllers with similar viral loads. We identified potential critical host and viral mediators of NSV that may represent targets to disrupt HIV-1 persistence.